rs559510809
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000038.6(APC):c.1262G>A(p.Trp421*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000038.6 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 1 Pathogenic:2
This variant is considered pathogenic. This variant creates a termination codon and is predicted to result in premature protein truncation. -
For these reasons, this sequence change has been classified as Pathogenic. Truncating sequence changes in APC are known to be pathogenic. Although this particular sequence change has not been published in the literature, another sequence change (c.1262_1263delinsAA), which also results in the same truncation (p.Trp421*), has been reported in a familial adenomatous polyposis case (PMID: 20924072). This sequence change has not been published in the literature and is not present in population databases. This sequence change creates a premature translational stop signal at codon 421 (p.Trp421*). It is expected to result in an absent or disrupted protein product. -
not provided Pathogenic:1
The APC c.1262G>A (p.Trp421*) variant causes the premature termination of APC protein synthesis. This variant has been reported in the published literature in an individual affected with familial adenomatous polyposis (PMID: 20924072 (2011)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Based on the available information, this variant is classified as pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.W421* pathogenic mutation (also known as c.1262G>A), located in coding exon 9 of the APC gene, results from a G to A substitution at nucleotide position 1262. This changes the amino acid from a tryptophan to a stop codon within coding exon 9. This mutation was found in one individual in a cohort of 136 Spanish individuals with Familial Adenomatous Polyposis (FAP) (Rivera B, Ann. Oncol. 2011 Apr; 22(4):903-9). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at